European Commission gives pharma, medtech industry opportunity for say on HTA network
This article was originally published in Clinica
Executive Summary
The European Commission is seeking feedback from drug and medical device companies and other interested parties on creating a network of national health technology appraisal bodies, as outlined in the cross border healthcare directive. The commission's musings are general at this stage, but the consultation hints at areas that might affect the way that national HTA agencies work and how far industry and other stakeholders might be involved, says EUCOPE, the European Confederation of Pharmaceutical Entrepreneurs.